BJO

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 30 August 2006. doi:10.1136/bjo.2006.101485
British Journal of Ophthalmology 2007;91:29-32
Copyright © 2007 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
bjo.2006.101485v1
91/1/29    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Malvitte, L
Right arrow Articles by Lizard, G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Malvitte, L
Right arrow Articles by Lizard, G

SCIENTIFIC REPORT

Measurement of inflammatory cytokines by multicytokine assay in tears of patients with glaucoma topically treated with chronic drugs

L Malvitte1,2, T Montange2, A Vejux2, C Baudouin3, A M Bron1, C Creuzot-Garcher1, G Lizard2

1 Department of Ophthalmology, University Hospital Dijon, Dijon, France
2 INSERM U498/IFR100, Métabolisme des Lipoprotéines et Interactions Vasculaires, University Hospital, Dijon, France
3 Department of Ophthalmology, Centre National Hospitalier d’Ophtalmologie, Paris, France

Correspondence to:
Correspondence to:
L Malvitte
CHU Dijon, Service d’Ophtalmologie, 3 rue du Faubourg Raines, 21000 Dijon, France; laure.malvitte{at}wanadoo.fr


ABSTRACT
Aim: To investigate the ocular surface inflammatory response to chronic topical treatments in patients with glaucoma by measuring the cytokine level in tears using multiplex bead analysis.

Methods: Tear samples were collected from 21 patients with glaucoma and 12 healthy volunteers. Tears were analysed for the presence of 17 cytokines: interleukin (IL)1ß, IL2, IL4, IL5, IL6, IL7, IL8, IL10, IL12, IL13, IL17, granulocyte-colony stimulating factor, granulocyte-macrophage stimulating factor, interferon (INF){gamma}, monocyte chemotactic protein (MCP)1, macrophage inflammatory protein 1ß and tumour necrosis factor (TNF){alpha}. The cytokines in each sample of tears were measured using multiplex bead analysis with microspheres as solid support for immunoassays.

Results: In the tears of treated patients, proinflammatory cytokines (IL1ß, IL6, IL12, TNF{alpha}) were significantly increased compared with controls. T helper (Th)1 (INF{gamma}, IL2) and Th2 (IL5, IL10, IL4) type cytokines were also significantly higher (p<0.05); however, the most marked increase was observed with Th1 cytokines. The expression of chemokine IL8 and MCP1 was also increased in the treated group.

Conclusion: This study shows that pro-inflammatory cytokine secretion by conjunctival cells is increased in response to topical treatments for glaucoma. The characterisation of cytokines in tears was previously limited by the small volume attainable, a limitation that has been overcome by multiplex analysis.


Abbreviations: BAC, benzalkonium chloride; HLA, human leucocyte antigen; IFN, interferon; MCP, monocyte chemotactic protein; MIP, macrophage inflammatory protein







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 by the BMJ Publishing Group Ltd.